Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines

Gemcitabine (GEM) and cisplatin (CDDP) combination therapy (GC) is the standard chemotherapy for advanced biliary tract cancer (BTC); however, its pharmacotherapeutic efficacy remains unclear. To investigate the effects of GC, we selected 11 from 17 BTC cell lines, according to their GEM sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Yasunari, Yamagishi, Seri, Okusaka, Takuji, Ojima, Hidenori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770112/
https://www.ncbi.nlm.nih.gov/pubmed/31484399
http://dx.doi.org/10.3390/cells8091026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770112/
https://www.ncbi.nlm.nih.gov/pubmed/31484399
http://dx.doi.org/10.3390/cells8091026

Ejemplares similares